To answer these questions and clarify the role for CD44 in VEGF‐promoted angiogenesis, we investigated the inhibitory effects of VEGF on CD44 expression and tumor invasion using cultured GSC lines because GSCs in the tumor border are thought to be causal cells expressing activated CD44. The gene discussed is CD44; the disease is neoplasm.